在糖尿病视网膜病变中,TGR5通过抑制GRP75介导的内质网膜-线粒体合来抑制cGAS/STING通路
Yan Li1, Lingpeng Zhu1,2, Meng-Xia Cai1
1Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, P. R. China.
TGR5激活通过防止线粒体功能障碍和穆勒细胞炎症来缓解糖尿病视网膜病变 (DR). 针对TGR5为DR治疗提供了一个有前途的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病的严重并发症,影响视网膜平衡.
- 穆勒质细胞对视网膜健康至关重要,它们的功能在DR中受损.
- 勒细胞中TGR5的作用及其在DR中的机制尚不清楚.
研究的目的:
- 在糖尿病条件下研究TGR5在米勒细胞功能中的作用.
- 阐明TGR5影响DR的潜在分子机制.
- 评估TGR5作为DR的潜在治疗点.
主要方法:
- 使用高葡萄糖治疗的人类穆勒细胞和链毒素诱导的糖尿病大鼠.
- 评估了线粒体功能,Ca2+稳态,以及IP3R1-GRP75-VDAC1轴.
- 检查了cGAS-STING通路激活,炎症标志物和视网膜损伤.
主要成果:
- 激活TGR5缓解了线粒体Ca2+过载和Müller细胞中的功能障碍.
- TGR5抑制了IP3R1-GRP75-VDAC1轴,防止了线粒体Ca2+的流入.
- 在DR模型中,TGR5激素减少了mtDNA释放,cGAS-STING激活,炎症和视网膜损伤.
结论:
- TGR5在穆勒细胞中起着保护性作用,防止糖尿病损伤.
- TGR5通过调节线粒体功能和抑制炎症通路来减轻DR.
- TGR5代表了治疗糖尿病视网膜病变的新治疗标.
更多相关视频
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
相关概念视频
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
